|
G |
AGT |
angiotensinogen |
increases abundance |
EXP |
AGT results in increased abundance of Aldosterone |
CTD |
PMID:2831029 |
|
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
|
|
G |
POMC |
proopiomelanocortin |
increases abundance |
EXP |
POMC protein results in increased abundance of Aldosterone |
CTD |
PMID:2831029 |
|
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
|
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases localization |
EXP |
blebbistatin results in decreased localization of ABCB11 protein |
CTD |
PMID:15826951 |
|
NCBI chr36:13,742,895...13,835,312
Ensembl chr36:13,746,964...13,834,974
|
|
|
G |
CRH |
corticotropin releasing hormone |
increases abundance |
EXP |
CRH protein results in increased abundance of Hydrocortisone |
CTD |
PMID:2831029 |
|
NCBI chr29:15,831,944...15,840,560
Ensembl chr29:15,831,944...15,834,384
|
|
G |
INS |
insulin |
affects abundance multiple interactions |
EXP |
INS protein affects the abundance of Hydrocortisone Sodium affects the reaction [INS protein affects the abundance of Hydrocortisone] |
CTD |
PMID:1324617 |
|
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
|
|
G |
POMC |
proopiomelanocortin |
increases abundance |
EXP |
POMC protein results in increased abundance of Hydrocortisone |
CTD |
PMID:2831029 |
|
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression multiple interactions affects response to substance |
EXP |
Doxorubicin results in increased expression of ABCB1 protein valspodar inhibits the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]; valspodar inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] |
CTD |
PMID:15492788 PMID:24975508 PMID:28093773 |
|
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
|
|
G |
HGF |
hepatocyte growth factor |
decreases response to substance |
EXP |
HGF protein results in decreased susceptibility to Doxorubicin |
CTD |
PMID:15688034 |
|
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
|
|
G |
TNNT2 |
troponin T2, cardiac type |
affects expression |
EXP |
Doxorubicin affects the expression of TNNT2 protein |
CTD |
PMID:12322705 |
|
NCBI chr 7:1,598,306...1,620,531
Ensembl chr 7:1,598,306...1,613,741
|
|
G |
VIP |
vasoactive intestinal peptide |
decreases expression |
EXP |
Doxorubicin results in decreased expression of VIP protein |
CTD |
PMID:3711722 |
|
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
affects response to substance |
EXP |
XIAP affects the susceptibility to Doxorubicin |
CTD |
PMID:16953886 |
|
NCBI chr X:95,300,234...95,356,103
Ensembl chr X:95,331,827...95,351,582
|
|
|
G |
INS |
insulin |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:12639917 |
|
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:12639917 |
|
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:12639917 |
|
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
|
|
G |
SLC6A9 |
solute carrier family 6 member 9 |
multiple interactions affects localization |
EXP |
Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein] Tetradecanoylphorbol Acetate affects the localization of SLC6A9 protein |
CTD |
PMID:19473961 |
|
NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
|
|
G |
SOD1 |
superoxide dismutase 1 |
affects response to substance |
EXP |
SOD1 protein affects the susceptibility to Tetradecanoylphorbol Acetate |
CTD |
PMID:6333936 |
|
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
|
|